Dentsply Sirona appoints Aldo Denti as chief commercial officer

CHARLOTTE - Dentsply Sirona Inc. (NASDAQ:XRAY), a $2.58 billion dental equipment manufacturer currently trading near its 52-week low of $12.95, has appointed Aldo M. Denti as Executive Vice President and Chief Commercial Officer, effective October 6, according to a press release statement.

The company said the new role is designed to align its Global Business Units and Commercial Organizations more closely to streamline operations and delivery.

Denti joins Dentsply Sirona after serving as Company Group Chairman of Global Orthopedics at Johnson & Johnson Medtech. He brings over 25 years of experience in the Medical Device and Consumer Health sectors.

"Aldo will lead our global sales strategy and execution to deliver superior growth, profitability, and customer satisfaction across all regions," said Daniel Scavilla, President and Chief Executive Officer of Dentsply Sirona.

The appointment aims to strengthen collaboration across business units and regions while leveraging the company’s portfolio of dental products and solutions.

Denti, who speaks six languages, previously held leadership positions at Johnson & Johnson Vision and various roles in Johnson & Johnson’s orthopedics business. His earlier career included positions at Pfizer, Medtronic, and Wright Medical.

Dentsply Sirona describes itself as the world’s largest diversified manufacturer of professional dental products and technologies, offering dental and oral health products as well as other consumable medical devices. The company maintains a strong 32-year track record of consistent dividend payments, and InvestingPro analysis indicates the stock is currently trading below its Fair Value, suggesting potential upside opportunity for investors.

In other recent news, Dentsply Sirona reported its second-quarter 2025 earnings, showing a slight beat on both earnings per share (EPS) and revenue forecasts. The company posted an EPS of $0.52, surpassing the expected $0.50, which represents a 7% growth compared to the previous year. Revenue was reported at $936 million, slightly above the forecast of $933.63 million, despite being a 5% decrease from the previous year. In other developments, Dentsply Sirona awarded a $2 million retention grant to its Chief Supply Chain Officer, Tony Johnson, to encourage his continued employment amid recent executive transitions. Meanwhile, Mizuho lowered its price target for Dentsply Sirona to $16.00, citing concerns over slightly lower margins and higher taxes impacting their outlook. Jefferies also adjusted its price target to $15.00, noting concerns over tariffs but maintaining a Hold rating as the company’s earnings and sales slightly exceeded prior consensus estimates. Needham maintained its Hold rating on Dentsply Sirona following the company’s DS World event. These updates reflect the company’s ongoing strategic and financial adjustments.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.